NIAID resources for researchers offers product development resources, cooperative research and materials licensing agreements, computational biology tools, global research and development projects, and more. The purpose is to facilitate the preclinical and clinical research needed to translate the ideas generated through basic research into safe and effective drugs, vaccines, and diagnostics to control and prevent allergic and infectious diseases.
Generally, you may request services if you are an investigator in academia, a not-for-profit organization, industry, or government in the United States or worldwide. You need not be a grantee of NIAID or another National Institutes of Health Institute or Center. Look to each service for further eligibility information.
Tools, datasets and services are organized by function, but you may also access them through lists organized by NIAID division:
- Division of AIDS
- Division of Allergy, Immunology, and Transplantation
- Division of Microbiology and Infectious Diseases
Computer applications have become an essential part of biomedical research to analyze the often huge amounts of data. NIAID develops and applies bioinformatics tools for sequencing and alignment, structural analysis and prediction, genome annotation, and simulations and 3D modeling.
- Genomics and DNA Analysis
- Proteomics and Protein Analysis
- Gene Expression and Transcriptome Analysis
- Systems Biology
NIAID supports the maintenance and distribution of materials for biomedical research. Items such as pathogen, host, and vector specimens; molecular reagents; and disease models belong in the public domain, to be used to pursue science that can improve the health of people worldwide. This technology is generally not meant for broad commercialization or sale to the public and so is not patented.
- Cell, Tissue, and Organism Repositories
- Primary Immunodeficiency Diseases Registry
- Model Animals
- Primary Immunodeficiency Disease DNA and Cell Repository
NIAID offers tools to assist investigators through clinical research, from research operations and management resources through data management and analysis. NIAID also offers existing networks that help to accelerate the clinical development of therapies, vaccines, and diagnostics.
- Biocontainment Facilities
- Preclinical and Clinical Research Resources
- Vaccines, Diagnostics, and Therapeutics
NIAID is constantly pursuing collaborations with industry and academia to develop its technologies and materials into products that improve public health. The Technology Transfer and Intellectual Property Office facilitates collaborative relationships between NIAID investigators and the broader scientific community.
- Model Agreements and Definitions
- Model Licenses and Definitions
- Licensing and Collaboration Opportunities
Addressing complex public health issues requires the combined efforts of government agencies, academic institutions, private-sector companies, and nonprofit organizations. Such partnerships help leverage resources, improve efficiency and cost-effectiveness, and increase the feasibility and scientific impact of the research.
- Consortia and Alliances
- Partnerships With Foreign Countries
- Public-Private Partnerships
- Technology Transfer Collaborations